Green Health & Wellness US FDA finds control lapses at Moderna manufacturing plant – GWC Mag gwcmagJanuary 18, 2024034 views Health 15 December 2023, 9:42 am 1 minute Reuters exclusively reported that U.S. drug regulators in September found quality control lapses at Moderna’s (MRNA.O) main factory including with equipment used to manufacture drug substance for its COVID-19 vaccine. Market Impact Moderna in September said it was in talks with its partners that fill vials and syringes with its COVID vaccine globally to downsize production and bring more manufacturing in-house as demand has waned. The vaccine maker said it expects additional capacity from its new mRNA manufacturing facilities in the UK, Canada and Australia when completed in 2025. Article Tags Topics of Interest: Health Type: Reuters Best Sectors: Government & Public ServicesPharmaceuticals & Healthcare Regions: Americas Countries: United States Win Types: Exclusivity Story Types: Exclusive / Scoop Media Types: Text Customer Impact: Significant National Story